Eurofins Scientific SE

Equities

ERF

FR0014000MR3

Healthcare Facilities & Services

Real-time Euronext Paris Other stock markets 03:55:30 04/07/2024 pm IST			5-day change	1st Jan Change
45.97 ^EUR	+3.21%		-2.21%	-22.08%

03/07	Eurofins Scientific Issues Second Rebuttal of Muddy Waters Allegations	MT
03/07	CAC40: up sharply despite gloomy PMIs	CF

Eurofins Scientific SE completed the acquisition of Biotech-Germande SAS.

January 31, 2016

Eurofins Scientific SA (ENXTPA:ERF) agreed to acquire Biotech-Germande SAS on December 3, 2015. Biotech-Germande SAS reported €2.5 million of revenues.

Eurofins Scientific SE (ENXTPA:ERF) completed the acquisition of Biotech-Germande SAS in January 2016.

Latest news about Eurofins Scientific SE

Eurofins Scientific Issues Second Rebuttal of Muddy Waters Allegations	03/07	MT
CAC40: up sharply despite gloomy PMIs	03/07	CF
Europe rebounds ahead of PMIs, supported by Powell	03/07	RE
Eurofins once again refutes Muddy Waters' allegations	03/07	RE
Eurofins: second denial of MW accusations	03/07	CF
New semester, new state of mind	01/07
Eurofins Scientific Unit to Sell Nightingale's Blood Analysis test in the US	28/06	MT
Market Update-Europe closes lower in a session marked by a wait-and-see attitude	25/06	RE
EUROFINS : Oddo BHF confirms its recommendation on the stock	25/06	CF
European shares fall as Airbus hammers aerospace shares, tech slips	25/06	RE
Eurofins: Muddy Waters' accusations rejected	25/06	CF
Europe in the red with tech and political risk	25/06	RE
Eurofins denies allegations of embezzlement by Muddy Waters	25/06	RE
EUROFINS SCIENTIFIC : Eurofins’ share price tanks after short seller report	24/06
European shares start the week higher on autos, banks	24/06	RE
Eurofins Scientific Faces Alleged 'Material Overstatements' from Muddy Waters Research	24/06	MT
MORNING BID AMERICAS-Transatlantic split reopens as half-year nears	24/06	RE
Lab testing firm Eurofins slumps after Muddy Waters report, short position	24/06	RE
Eurofins falls after allegations of financial irregularities by Muddy Waters	24/06	RE
European shares start week on bright footing on autos, banks' boost	24/06	RE
Europe opens hesitant as metal prices fall	24/06	RE
Enzymatica AB Announces Interim Results from Independent Clinical Study of Coldzyme® Show Duration of Illness Lowered by Approximately 5 Days	13/06	CI
EUROFINS SCIENTIFIC : EPS cut (2023: -28.6%, 2024: -18.4%)	31/05
Eurofins Scientific to Expand US Battery Materials Testing Capabilities	13/05	MT
Eurofins Scientific expands capacity in the USA	13/05	CF

Chart Eurofins Scientific SE

Duration

Period

More charts

Company Profile

Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).

Sector

Healthcare Facilities & Services

Calendar

24/07/2024 - Q2 2024 Earnings Release

Related indices

CAC 40 , STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

EUROFINS SCIENTIFIC : Eurofins’ share price tanks after short seller report

June 24, 2024 at 10:16 pm IST

More Strategies

Ratings for Eurofins Scientific SE

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

44.54 EUR

Average target price

59.69 EUR

Spread / Average Target

+34.01%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
EUROFINS SCIENTIFIC SE	-22.08%	9.28B
HCA HEALTHCARE, INC.	+20.64%	85.53B
CVS HEALTH CORPORATION	-28.19%	71.18B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.35%	26.41B
FRESENIUS SE & CO. KGAA	+1.64%	17.32B
LABCORP HOLDINGS INC.	-10.31%	17.18B
QUEST DIAGNOSTICS INCORPORATED	+2.19%	15.65B
NATERA, INC.	+78.22%	13.71B
TENET HEALTHCARE CORPORATION	+79.75%	13.27B
PURE HEALTH HOLDING	-23.86%	13.28B

Other Healthcare Facilities & Services